SP-40,40 is a constituent of Alzheimer's amyloid
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Cerebrospinal fluid (CSF), serum and seminal plasma contain a small amount of SP-40,40, a modulatory protein of the human complement system. The SP-40,40 in each body fluid was different in molecular size on SDS-PAGE, and glioblastoma cells, hepatoma cells and testicular tumor cells produced SP-40,40, while neuroblastoma cells did not. Therefore, it was estimated that CSF SP-40,40 originated in glia cells, serum SP-40,40 in liver cells and seminal plasma SP-40,40 in testicular cells. SP-40,40 concentrations in CSF of the patients with Alzheimer's disease and the patients with cerebral tumor were higher than those of normal donors. beta-Amyloid deposits in the brains of the patients with Alzheimer's disease were stained with an anti-SP-40,40 monoclonal antibody (mAb) but not with an anti-S-protein mAb, while cellular processes around beta-amyloid were stained with an anti-S-protein mAb but not with an anti-SP-40,40 mAb. Therefore, beta-amyloid contained SP-40,40 in a form different from that in the soluble membrane attack complex (SMAC, SC5b-9) of the complement, which contains S-protein as well as SP-40,40.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clusterin, which is secreted by astrocytes, has been found to complex to soluble Aβ [35], is present in plaques [36–38], and directly activates microglia [39].”
From Microglial dysfunction in brain aging and Alzheimer's disease (2014) · cites this paper as [36]
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961 · cited 1×
“SDS-PAGE was performed according to Laemmli [ 16 ] using 10 % polyacrylamide gel.”
MethodRaza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
[1] Preparation of monoclonal antibodies: Strategies and procedures
Galfrè, G., & Milstein, C. (1981) · Methods in Enzymology · doi:10.1016/0076-6879(81)73054-4 · Cited by 1,771
Abraham, C. R., Selkoe, D. J., & Potter, H. (1988) · Cell · doi:10.1016/0092-8674(88)90462-x · Cited by 900 · cited 1×
“A remarkable feature of SP-40,40 was its specific accumulation in ~-amyloid deposits in the brains of the patients with AD. Several proteins such as amyloid P component [6], complement proteins (Clq, C3 fragments and C4) [8] and cq-antichymotrypsin [ 1 ] are also accumulated in ~-amyloid of AD. At present no functiona…”
BackgroundImmunoglobulins and complement factors in senile plaques: An immunoperoxidase study
Eikelenboom, P., & Stam, F. C. (1982) · Acta Neuropathologica · doi:10.1007/bf00685397 · Cited by 454
Jenne, D. E., & Tschopp, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.7123 · Cited by 414
Biosynthesis and molecular cloning of sulfated glycoprotein 2 secreted by rat Sertoli cells
Collard, M. W., & Griswold, M. D. (1987) · Biochemistry · doi:10.1021/bi00386a008 · Cited by 330 · cited 1×
“SGP-2 appears to participate in the spermatogenesis [ 5 ].”
BackgroundMurphy, B. F., Kirszbaum, L., Walker, I. D., & d'Apice, A. J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113531 · Cited by 313 · cited 1×
“SP-40,40 was discovered as a component in the soluble membrane attack complex (SMAC, SC5b-9) of human complement [2, 18 ].”
BackgroundMassive somatodendritic sprouting of cortical neurons in Alzheimer's disease
Ihara, Y. (1988) · Brain Research · doi:10.1016/0006-8993(88)90293-4 · Cited by 304 · cited 1×
“Staining of sections of formalin-fixed brain was performed according to Ihara [ 12 ].”
MethodSelf-citationChanges in brain gene expression shared by scrapie and Alzheimer disease.
Duguid, J. R., Bohmont, C. W., Liu, N. G., & Tourtellotte, W. W. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.7260 · Cited by 251 · cited 3×
“Although Duguid [ 7 ] reported that SP-40,40-1ike mRNA markedly increased in hippocampus from the patients with AD, the concentration of SP-40,40 in CSF from the patients with AD was not as high as expected.”
BackgroundInfluential
Cited by
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.
Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,480
Self-citationAlzheimer’s Disease: The Challenge of the Second Century
Holtzman, D. M., Morris, J. C., & Goate, A. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002369 · Cited by 1,424
“In addition to apoE, there are other Ab-binding molecules, such as apolipoprotein J/clusterin (132, 133), a2-macroglobulin (a2-M) (134), transthyretin (135), and a1-antichymotrypsin (136), that may play a role in Ab aggregation in the brain by influencing cellular uptake and degradation of Ab locally by cells, its loc…”
BackgroundIwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316
Holtzman, D. M., Bales, K. R., Tenkova, T., Fagan, A. M., Parsadanian, M., Sartorius, L. J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050004797 · Cited by 937
Microglial dysfunction in brain aging and Alzheimer's disease
Mosher, K. I., & Wyss-Coray, T. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.008 · Cited by 618
“Clusterin, which is secreted by astrocytes, has been found to complex to soluble Ab [35], is present in plaques [36–38], and directly activates microglia”
BackgroundInflammation and Alzheimer's disease pathogenesis
Rogers, J., Webster, S., Lue, L.-F., Brachova, L., Harold Civin, W., Emmerling, M., Shivers, B., Walker, D., & McGeer, P. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00115-7 · Cited by 442
The toxicity in vitro of β-amyloid protein
Iversen, L. L., Mortishire-Smith, R. J., Pollack, S. J., & Shearman, M. S. (1995) · Biochemical Journal · doi:10.1042/bj3110001 · Cited by 429
Clusterin: Physiologic and pathophysiologic considerations
Rosenberg, M. E., & Silkensen, J. (1995) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/1357-2725(95)00027-m · Cited by 426
Transthyretin sequesters amyloid beta protein and prevents amyloid formation.
Schwarzman, A. L., Gregori, L., Vitek, M. P., Lyubski, S., Strittmatter, W. J., Enghilde, J. J., Bhasin, R., Silverman, J., Weisgraber, K. H., & Coyle, P. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8368 · Cited by 413
Butyrylcholinesterase in the life cycle of amyloid plaques
Guillozet, A. L., Mesulam, M. ‐., Smiley, J. F., & Mash, D. C. (1997) · Annals of Neurology · doi:10.1002/ana.410420613 · Cited by 310
Ghiso, J., Matsubara, E., Koudinov, A., Choi-Miura, N. H., Tomita, M., Wisniewski, T., & Frangione, B. (1993) · Biochemical Journal · doi:10.1042/bj2930027 · Cited by 304
Self-citationNascent astrocyte particles differ from lipoproteins in CSF
LaDu, M. J., Gilligan, S. M., Lukens, J. R., Cabana, V. G., Reardon, C. A., Van Eldik, L. J., & Holtzman, D. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052070.x · Cited by 285
The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β1−40 peptide
Narayan, P., Orte, A., Clarke, R. W., Bolognesi, B., Hook, S., Ganzinger, K. A., Meehan, S., Wilson, M. R., Dobson, C. M., & Klenerman, D. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2191 · Cited by 282
Apolipoprotein J (clusterin) and Alzheimer's disease
Calero, M., Rostagno, A., Matsubara, E., Zlokovic, B., Frangione, B., & Ghiso, J. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20000815)50:4<305::aid-jemt10>3.0.co;2-l · Cited by 256
Bates, K. A., Verdile, G., Li, Q.-X., Ames, D., Hudson, P., Masters, C. L., & Martins, R. N. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.96 · Cited by 247
Floyd, R. A. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00293-7 · Cited by 241
Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease
Martins, I. J., Berger, T., Sharman, M. J., Verdile, G., Fuller, S. J., & Martins, R. N. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06408.x · Cited by 232
Cholesterol homeostasis in neurons and glial cells
Vance, J. E., Hayashi, H., & Karten, B. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2005.01.005 · Cited by 224
Fagan, A. M., Holtzman, D. M., Munson, G., Mathur, T., Schneider, D., Chang, L. K., Getz, G. S., Reardon, C. A., Lukens, J., Shah, J. A., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30001 · Cited by 222
Song, F., Poljak, A., Crawford, J., Kochan, N. A., Wen, W., Cameron, B., Lux, O., Brodaty, H., Mather, K., Smythe, G. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034078 · Cited by 214
Bertrand, P., Poirier, J., Oda, T., Finch, C. E., & Pasinetti, G. M. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00097-c · Cited by 210
The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease
Beffert, U. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00008-3 · Cited by 189
Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid
Borghini, I., Barja, F., Pometta, D., & James, R. W. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)00232-n · Cited by 182
DeMattos, R. B., Brendza, R. P., Heuser, J. E., Kierson, M., Cirrito, J. R., Fryer, J., Sullivan, P. M., Fagan, A. M., Han, X., & Holtzman, D. M. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00049-3 · Cited by 180
Codeposition of Cystatin C with Amyloid-β Protein in the Brain of Alzheimer Disease Patients
Levy, E., Sastre, M., Kumar, A., Gallo, G., Piccardo, P., Ghetti, B., & Tagliavini, F. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.1.94 · Cited by 170
Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration
May, P. C., & Finch, C. E. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90190-j · Cited by 170
Current status on Alzheimer disease molecular genetics: from past, to present, to future
Bettens, K., Sleegers, K., & Van Broeckhoven, C. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq142 · Cited by 169
“Present in amyloid deposits (42), CLU has an increased expression in several AD brain regions (43).”
BackgroundLipoproteins in the Central Nervous System
LADU, M. J., REARDON, C., VAN ELDIK, L., FAGAN, A. M., BU, G., HOLTZMAN, D., & GETZ, G. S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06365.x · Cited by 167
Lidström, A.-M., Bogdanovic, N., Hesse, C., Volkman, I., Davidsson, P., & Blennow, K. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6892 · Cited by 163
Disrupting β-Amyloid Aggregation for Alzheimer Disease Treatment
Estrada, L., & Soto, C. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607779318262 · Cited by 162
Phosphatidylinositol and inositol involvement in alzheimer amyloid-β fibril growth and arrest
McLaurin, J., Franklin, T., Chakrabartty, A., & Fraser, P. E. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1677 · Cited by 163
Characterization of Apolipoprotein J-Alzheimer's Aβ Interaction
Matsubara, E., Frangione, B., & Ghiso, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7563 · Cited by 153
Wilson, M. R., Yerbury, J. J., & Poon, S. (2007) · Molecular BioSystems · doi:10.1039/b712728f · Cited by 142
The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome
Drummond, E., Kavanagh, T., Pires, G., Marta-Ariza, M., Kanshin, E., Nayak, S., Faustin, A., Berdah, V., Ueberheide, B., & Wisniewski, T. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01356-1 · Cited by 137
“0 Yes [95] Increased Increases pathology [7, 96]”
Biology of Aβ Amyloid in Alzheimer's Disease
Wisniewski, T., Ghiso, J., & Frangione, B. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0147 · Cited by 134
Potential role of apolipoprotein-E in fibrillogenesis.
Gallo, G., Wısnıewskı, T., Choi-Miura, N.-H., Ghiso, J. A., & Frangione, B. (1994) · PubMed · Cited by 131
Self-citationGerl, V. B., Bohl, J., Pitz, S., Stoffelns, B. M., Pfeiffer, N., & Bhakdi, S. (2002) · PubMed · Cited by 129
Pasinetti, G. M. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00113-3 · Cited by 121
Itagaki, S., Akiyama, H., Saito, H., & McGeer, P. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)91640-3 · Cited by 119
LaDu, M. J., Shah, J. A., Reardon, C. A., Getz, G. S., Bu, G., Hu, J., Guo, L., & Van Eldik, L. J. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00050-x · Cited by 118
Eikelenboom, P., Hoozemans, J. J., Veerhuis, R., van Exel, E., Rozemuller, A. J., & van Gool, W. A. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt118 · Cited by 109
Alzheimer's disease and soluble Aβ
Wısnıewskı, T., Ghiso, J. A., & Frangione, B. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90105-8 · Cited by 118
Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis.
Wısnıewskı, T., Golabek, A. A., Kida, E., Wisniewski, K. E., & Frangione, B. (1995) · Europe PMC (PubMed Central) · Cited by 117
The role of complement in Alzheimer’s disease pathology
Emmerling, M. R., Watson, M. D., Raby, C. A., & Spiegel, K. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00042-9 · Cited by 118
Clusterin Biogenesis Is Altered during Apoptosis in the Regressing Rat Ventral Prostate
Lakins, J., Bennett, S. A. L., Chen, J.-H., Arnold, J. M., Morrissey, C., Wong, P., O'Sullivan, J., & Tenniswood, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.27887 · Cited by 107
BRI2 Interacts with Amyloid Precursor Protein (APP) and Regulates Amyloid β (Aβ) Production
Fotinopoulou, A., Tsachaki, M., Vlavaki, M., Poulopoulos, A., Rostagno, A., Frangione, B., Ghiso, J., & Efthimiopoulos, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500231200 · Cited by 114
The interaction of heparan sulfate proteoglycans with the amyloid β protein.
Timmer, N. (2011) · Radboud Repository (Radboud University) · Cited by 122
Binding of Gelsolin, a Secretory Protein, to Amyloid β-Protein
Chauhan, V. P. S., Ray, I., Chauhan, A., & Wísniewski, H. M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0623 · Cited by 106
Eikelenboom, P., Rozemüller, A. J. M., & Muiswinkel, F. L. V. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6920 · Cited by 106
Nilselid, A.-M., Davidsson, P., Nägga, K., Andreasen, N., Fredman, P., & Blennow, K. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.12.005 · Cited by 104
Apolipoprotein E Receptors Mediate the Effects of β-Amyloid on Astrocyte Cultures
LaDu, M. J., Shah, J. A., Reardon, C. A., Getz, G. S., Bu, G., Hu, J., Guo, L., & Van Eldik, L. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000602200 · Cited by 103
Amyloid β binding proteins in vitro and in normal human cerebrospinal fluid
Golabek, A., Marques, M. A., Lalowski, M., & Wisniewski, T. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11565-7 · Cited by 99
Functional and structural properties of lipid-associated apolipoprotein J (clusterin)
CALERO, M., TOKUDA, T., ROSTAGNO, A., KUMAR, A., ZLOKOVIC, B., FRANGIONE, B., & GHISO, J. (1999) · Biochemical Journal · doi:10.1042/bj3440375 · Cited by 98
Sasaki, K., Doh‐ura, K., Wakisaka, Y., & Iwaki, T. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0546-4 · Cited by 98
Clusterin and Alzheimer’s Disease
Calero, M., Rostagno, A. A., Frangione, B., & Ghiso, J. A. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_14 · Cited by 98
ApoE and Aβ1–42 Interactions: Effects of Isoform and Conformation on Structure and Function
Manelli, A. M., Stine, W. B., Van Eldik, L. J., & LaDu, M. J. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:3:235 · Cited by 95
Eikelenboom, P., Veerhuis, R., van Exel, E., J.M. Hoozemans, J., J.M. Rozemuller, A., & A. van Gool, W. (2011) · Current Alzheimer Research · doi:10.2174/156720511795256080 · Cited by 88
“These so-called A -associated proteins include complement proteins, 1-antichymotrypsin (ACT), ApoE, clusterin, ICAM-1, 2-macroglobulin, serum amyloid P component (SAP) and heparan sulphate proteoglycans [6, 7, 11, 12, 13, 27-33].”
BackgroundVascular abnormalities: the insidious pathogenesis of Alzheimer’s disease☆
Shi, J., Perry, G. L., Smith, M. A., & Friedland, R. P. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00119-6 · Cited by 95
Localization of sulfated glycoprotein‐2/clusterin mRNA in the rat brain by in situ hybridization
Danik, M., Chabot, J. ‐., Hassan‐gonzalez, D., Suh, M., & Quirion, R. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903340205 · Cited by 84
Giannakopoulos, P., Kövari, E., French, L. E., Viard, I., Hof, P. R., & Bouras, C. (1998) · Acta Neuropathologica · doi:10.1007/s004010050815 · Cited by 90
Fagan, A. M., & Holtzman, D. M. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20000815)50:4<297::aid-jemt9>3.0.co;2-c · Cited by 80
Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3
Rebeck, G. W., Kindy, M., & LaDu, M. J. (2002) · Journal of Alzheimer's Disease · doi:10.3233/jad-2002-4304 · Cited by 89
“ApoE is a component of senile plaques and peripheral A β deposits [17,93,151], and apoE also associates with soluble oligomers of A β found in the brain, plasma and CSF [63,152].”
Lipoproteins in the Central Nervous System: From Biology to Pathobiology
Raulin, A.-C., Martens, Y. A., & Bu, G. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-032620-104801 · Cited by 89
Genetics of Clusterin Isoform Expression and Alzheimer's Disease Risk
Ling, I.-F., Bhongsatiern, J., Simpson, J. F., Fardo, D. W., & Estus, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033923 · Cited by 76
“…by several lines of evidence, including (I) CLU mRNA and clusterin protein is increased in AD [5,6], (ii) clusterin is a component of plaques [4,5,7], (iii) clusterin modulates AD-related pathways such as inflammation and apoptosis [1,8,9] and (iv) clusterin acts as an amyloid-beta (Aß)…”
Kida, E., Pluta, R. M., Lossinsky, A. S., Golabek, A. A., Choi-Miura, N.-H., Wisniewski, H. M., & Mossakowski, M. J. (1995) · Brain Research · doi:10.1016/0006-8993(94)01467-v · Cited by 87
Self-citationMorgan, T. E., Laping, N. J., Rozovsky, I., Oda, T., Hogan, T. H., Finch, C. E., & Pasinetti, G. M. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)00194-s · Cited by 82
The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model
Yuste-Checa, P., Trinkaus, V. A., Riera-Tur, I., Imamoglu, R., Schaller, T. F., Wang, H., Dudanova, I., Hipp, M. S., Bracher, A., & Hartl, F. U. (2021) · Nature Communications · doi:10.1038/s41467-021-25060-1 · Cited by 77
Isolation and Characterization of Apolipoproteins from Murine Microglia
Xu, Q., Li, Y., Cyras, C., Sanan, D. A., & Cordell, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002796200 · Cited by 69
Lipid Metabolism and Glial Lipoproteins in the Central Nervous System
Hayashi, H. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.453 · Cited by 80
Kida, E., Choi-Miura, N.-H., & Wisniewski, K. E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00482-6 · Cited by 79
Self-citationNavarro, A., del Valle, E., Astudillo, A., del Rey, C. G., & Tolivia, J. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00315-7 · Cited by 72
“(Choi-Miura et al., 1992; Ghiso et al., 1994; Petit-Turcotte et al., 2001; Zlokovic et al., 1994).”
BackgroundThe Immunopathology of Alzheimer's Disease and Some Related Disorders
Kalaria, R. N. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00761.x · Cited by 69
Unifying features of systemic and cerebral amyloidosis
Ghiso, J. A., Wısnıewskı, T., & Frangione, B. (1994) · Molecular Neurobiology · doi:10.1007/bf02778007 · Cited by 69
Clusterin in Alzheimer's disease
Wu, Z., Yu, J., Li, Y., & Tan, L. (2012) · Advances in clinical chemistry · doi:10.1016/b978-0-12-394317-0.00011-x · Cited by 67
Clusterin contributes to early stage of Alzheimer's disease pathogenesis
Oh, S., Kim, M. S., Park, S., Son, H., Kim, S., Kim, M., Jo, D., Tak, E., & Lee, J. (2019) · Brain Pathology · doi:10.1111/bpa.12660 · Cited by 58
“In patients with AD, clusterin levels are even higher in the brain (14,33,40), serum and cerebrospinal fluid (CSF) (8,13).”
BackgroundResultInfluentialClusterin: an enigmatic protein recruited by diverse stimuli.
Rosenberg, M. E., Dvergsten, J., & Correa‐Rotter, R. (1993) · PubMed · Cited by 65
Rostagno, A. A., Tomidokoro, Y., Lashley, T., Ng, D., Plant, G. T., Holton, J. L., Frangione, B., Révész, T., & Ghiso, J. A. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5092-5 · Cited by 64
Apolipoprotein E Carboxyl-terminal Fragments Are Complexed to Amyloids A and L
Castaño, E. M., Prelli, F., Pras, M., & Frangione, B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17610 · Cited by 59
Li, X., Miyajima, M., Mineki, R., Taka, H., Murayama, K., & Arai, H. (2006) · Acta Neurochirurgica · doi:10.1007/s00701-006-0787-4 · Cited by 62
“The CSF levels of ACT, apoJ, apoD, and haptoglobin 1 were also higher in patients with AD [5, 9, 13, 23].”
Tycko, B., Feng, L., Nguyen, L., Francis, A., Hays, A., Chung, W.-Y., Tang, M.-X., Stern, Y., Sahota, A., Hendrie, H., et al. (1996) · Human Genetics · doi:10.1007/s004390050234 · Cited by 61
Relationship Between Multifunctional Protein "Clusterin" and Alzheimer Disease
Choi-Miura, N.-H., & Oda, T. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00106-6 · Cited by 60
Self-citationClusterin in neurological disorders: Molecular perspectives and clinical relevance
Charnay, Y., Imhof, A., Vallet, P. G., Kovari, E., Bouras, C., & Giannakopoulos, P. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.05.006 · Cited by 53
Traumatic brain injury induces biphasic upregulation of ApoE and ApoJ protein in rats
Iwata, A., Browne, K. D., Chen, X.-H., Yuguchi, T., & Smith, D. H. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20607 · Cited by 55
“Overexpression of ApoJ mRNA has been observed in injury, chronic inflammation of the brain, and numerous neurodegenerative conditions such as AD (May et al., 1990; Choi-Miura et al., 1992; McGeer et al., 1992; Ghiso et al., 1993; Maat-Schieman et al., 1996; Calero et al., 2000).”
BackgroundSasaki, K., Doh‐ura, K., Ironside, J. W., & Iwaki, T. (2001) · Acta Neuropathologica · doi:10.1007/s004010100456 · Cited by 56
Soto, C., Castaño, E. M., Prelli, F., Asok Kumar, R., & Baumann, M. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00863-5 · Cited by 52
Martin-Rehrmann, M. D., Hoe, H., Capuani, E. M., & Rebeck, G. W. (2005) · Neurotoxicity Research · doi:10.1007/bf03036452 · Cited by 55
“ApoJ has been found in AD cortex in both diffuse and compact plaques (Choi-Miura et al., 1992; McGeer et al., 1992; Kida et al., 1995; Harr et al., 1996) and in Down's syndrome in compact plaques (Kida et al., 1995; Stoltzner et al., 2002).”
Clusterin solubility and aggregation in Creutzfeldt-Jakob disease
Freixes, M., Puig, B., Rodr�guez, A. C., Torrejón-Escribano, B., Blanco, R., & Ferrer, I. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0891-6 · Cited by 55
Apolipoprotein J (clusterin) activates rodent microglia in vivo and in vitro
Xie, Z., Harris‐White, M. E., Wals, P. A., Frautschy, S. A., Finch, C. E., & Morgan, T. E. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03065.x · Cited by 53
Oyama, F., Murakami, N., & Ihara, Y. (1998) · Neuroscience Research · doi:10.1016/s0168-0102(98)00020-0 · Cited by 51
Self-citationApolipoprotein J/clusterin induction in myocarditis: A localized response gene to myocardial injury.
Swertfeger, D. K., Witte, D. P., Stuart, W. D., Rockman, H. A., & Harmony, J. A. K. (1996) · Europe PMC (PubMed Central) · Cited by 48
Kalaria, R. N., & Perry, G. L. (1993) · Brain Research · doi:10.1016/0006-8993(93)91202-4 · Cited by 48
A model for modulation of leptin activity by association with clusterin
Bajari, T. M., Strasser, V., Nimpf, J., & Schneider, W. J. (2003) · The FASEB Journal · doi:10.1096/fj.02-1106fje · Cited by 45
“Clusterin is also present in several other body fluids, such as milk (19), cerebrospinal fluid (20), and seminal fluid (21), where it may or may not be associated with lipoproteins.”
BackgroundInjury‐induced Synthesis and Release of Apolipoprotein E and Clusterin from Rat Neural Cells
Messmer‐Joudrier, S., Sagot, Y., Mattenberger, L., James, R. W., & Kato, A. C. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01560.x · Cited by 41
Ferrer, I., Carmona, M., Blanco, R., Moreno, D., Torrejón-Escribano, B., & Olivé, M. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00504.x · Cited by 42
“Clusterin is associated with abnormal protein accumulations in several neurodegenerative diseases, including amyloidopathies (ie, βA-amyloid plaques in Alzheimer disease), prionopathies and α-synucleinopathies (3, 5, 15, 25, 36, 47, 52).”
BackgroundClusterin in the eye: An old dog with new tricks at the ocular surface
Fini, M. E., Bauskar, A., Jeong, S., & Wilson, M. R. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.04.019 · Cited by 41
Michel, D., Moyse, E., Trembleau, A., Jourdan, F., & Brun, G. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.14.1635 · Cited by 40
The chaperone Clusterin in neurodegeneration−friend or foe?
Yuste‐Checa, P., Bracher, A., & Hartl, F. U. (2022) · BioEssays · doi:10.1002/bies.202100287 · Cited by 37
Complexes of Amyloid-β and Cystatin C in the Human Central Nervous System
Mi, W., Jung, S. S., Yu, H., Schmidt, S. D., Nixon, R. A., Mathews, P. M., Tagliavini, F., & Levy, E. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1147 · Cited by 34
“…brain parenchyma and in vascular walls, minor components were identified, such as P-component [1], apolipoprotein E (ApoE) [2], apolipoprotein J [3,4], proteoglycans [5], lysosomal proteinases [6–8], and the proteinases inhibitors, α 1-antichymotrypsin, α 1-antitrypsin [9], and α 2 -macroglobulin…”
Complement Involvement in Neovascular Ocular Diseases
Yanai, R., Thanos, A., & Connor, K. M. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0106-3_10 · Cited by 38
V-src-induced-transcription of the avian clusterin gene
Hérault, Y., Chatelain, G., Brun, G., & Michel, D. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.23.6377 · Cited by 38
Metadata
- Authors
- Choi-Miura, N. H., Ihara, Y., Fukuchi, K., Takeda, M., Nakano, Y., Tobe, T., & Tomita, M.
- Affiliations
- SHOWA Medical University (JP)
- Tokyo Metropolitan Institute of Gerontology (JP)
- Venue
- Acta Neuropathologica
- Published
- 1992-02
- Volume
- 83
- Issue
- 3
- Pages
- 260-264
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2089421296
- Cited by
- 158
- References
- 21
- Citations by year
- 2026: 2 · 2025: 1 · 2022: 6 · 2021: 3 · 2018: 2 · 2017: 2 · 2016: 3 · 2014: 2 · 2013: 1 · 2012: 6
- FWCI
- 7.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, complement system, S protein, cerebrospinal fluid, seminal plasma, serum, glioblastoma, membrane attack complex, sC5b-9, amyloid deposits, monoclonal antibodies
- MeSH terms
- Alzheimer Disease, Amyloid, Antibodies, Blood Proteins, Enzyme-Linked Immunosorbent Assay, Glycoproteins, Humans, Staining and Labeling, Sulfates, Tumor Cells, Cultured, Molecular Chaperones, Clusterin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.